avantor inc. - AVTR

AVTR

Close Chg Chg %
7.77 0.13 1.67%

Closed Market

7.90

+0.13 (1.67%)

Volume: 5.10M

Last Updated:

Apr 2, 2026, 3:59 PM EDT

Company Overview: avantor inc. - AVTR

AVTR Key Data

Open

$7.66

Day Range

7.59 - 8.07

52 Week Range

7.27 - 16.17

Market Cap

$5.39B

Shares Outstanding

682.06M

Public Float

662.99M

Beta

1.00

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$0.78

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

9.61M

 

AVTR Performance

1 Week
 
6.61%
 
1 Month
 
-3.30%
 
3 Months
 
-31.06%
 
1 Year
 
-47.79%
 
5 Years
 
-73.17%
 

AVTR Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 20
Full Ratings ➔

About avantor inc. - AVTR

Avantor, Inc. is a life science tools company that engages in providing mission-critical products and services to the life sciences and advanced technology industries. Its portfolio includes biopharma, healthcare, education and government, as well as advanced technologies and applied materials industries. It sells materials, equipment, instrumentation, and offers specialty procurement. The company operates through the Laboratory Solutions segment and Bioscience Production. The Laboratory Solutions segment focuses on research, diagnostic, and quality control workflows. The Bioscience Production segment focuses on high-purity materials for bioprocessing and medical technologies. Avantor was founded by John Townsend Baker in 1904 and is headquartered in Radnor, PA.

AVTR At a Glance

Avantor, Inc.
One Radnor Corporate Center
Radnor, Pennsylvania 19087-4515
Phone 1-610-386-1700 Revenue 6.55B
Industry Medical Specialties Net Income -530,200,000.00
Sector Health Technology Employees 13,500
Fiscal Year-end 12 / 2026
View SEC Filings

AVTR Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 1.19
Price to Book Ratio 1.404
Price to Cash Flow Ratio 12.50
Enterprise Value to EBITDA 11.59
Enterprise Value to Sales 1.765
Total Debt to Enterprise Value 0.357

AVTR Efficiency

Revenue/Employee 485,348.148
Income Per Employee -39,274.074
Receivables Turnover 6.097
Total Asset Turnover 0.548

AVTR Liquidity

Current Ratio 1.778
Quick Ratio 1.184
Cash Ratio 0.265

AVTR Profitability

Gross Margin 28.056
Operating Margin 8.97
Pretax Margin -6.735
Net Margin -8.092
Return on Assets -4.435
Return on Equity -9.204
Return on Total Capital -5.468
Return on Invested Capital -5.591

AVTR Capital Structure

Total Debt to Total Equity 74.246
Total Debt to Total Capital 42.61
Total Debt to Total Assets 35.031
Long-Term Debt to Equity 73.091
Long-Term Debt to Total Capital 41.947
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Avantor Inc. - AVTR

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
7.51B 6.97B 6.78B 6.55B
Sales Growth
+1.71% -7.26% -2.64% -3.41%
Cost of Goods Sold (COGS) incl D&A
5.23B 4.91B 4.80B 4.71B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
405.50M 402.30M 405.50M 410.20M
Depreciation
87.20M 94.60M 105.70M 109.10M
Amortization of Intangibles
318.30M 307.70M 299.80M 301.10M
COGS Growth
+1.04% -6.06% -2.18% -1.88%
Gross Income
2.28B 2.06B 1.98B 1.84B
Gross Income Growth
+3.28% -10.00% -3.73% -7.13%
Gross Profit Margin
+30.41% +29.51% +29.18% +28.06%
2022 2023 2024 2025 5-year trend
SG&A Expense
1.13B 1.16B 1.25B 1.25B
Research & Development
- - - -
-
Other SG&A
1.13B 1.16B 1.25B 1.25B
SGA Growth
-0.80% +2.46% +7.75% +0.10%
Other Operating Expense
- - - -
-
Unusual Expense
25.50M 194.50M 90.20M 824.20M
EBIT after Unusual Expense
1.13B 702.20M 640.00M (236.50M)
Non Operating Income/Expense
(2.70M) 23.80M 542.20M 16.80M
Non-Operating Interest Income
- - 75.10M 42.20M
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
273.60M 315.50M 328.30M 221.60M
Interest Expense Growth
+25.85% +15.31% +4.06% -32.50%
Gross Interest Expense
273.60M 315.50M 328.30M 221.60M
Interest Capitalized
- - - -
-
Pretax Income
851.10M 410.50M 853.90M (441.30M)
Pretax Income Growth
+13.03% -51.77% +108.01% -151.68%
Pretax Margin
+11.33% +5.89% +12.59% -6.74%
Income Tax
164.60M 89.40M 142.40M 88.90M
Income Tax - Current - Domestic
152.10M 146.20M 128.00M 34.40M
Income Tax - Current - Foreign
81.60M 115.60M 61.30M 46.80M
Income Tax - Deferred - Domestic
(22.40M) (19.80M) (18.10M) 3.10M
Income Tax - Deferred - Foreign
(46.70M) (152.60M) (28.80M) 4.60M
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
686.50M 321.10M 711.50M (530.20M)
Minority Interest Expense
- - - -
-
Net Income
686.50M 321.10M 711.50M (530.20M)
Net Income Growth
+19.89% -53.23% +121.58% -174.52%
Net Margin Growth
+9.14% +4.61% +10.49% -8.09%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
686.50M 321.10M 711.50M (530.20M)
Preferred Dividends
- - - 24.20M
-
Net Income Available to Common
662.30M 321.10M 711.50M (530.20M)
EPS (Basic)
1.0175 0.4753 1.0469 -0.779
EPS (Basic) Growth
+18.27% -53.29% +120.26% -174.41%
Basic Shares Outstanding
650.90M 675.60M 679.60M 680.60M
EPS (Diluted)
1.0104 0.4733 1.0434 -0.779
EPS (Diluted) Growth
+19.26% -53.16% +120.45% -174.66%
Diluted Shares Outstanding
679.40M 678.40M 681.90M 680.60M
EBITDA
1.56B 1.30B 1.14B 997.90M
EBITDA Growth
+7.45% -16.65% -12.57% -12.13%
EBITDA Margin
+20.74% +18.64% +16.74% +15.23%

Snapshot

Average Recommendation HOLD Average Target Price 10.60
Number of Ratings 20 Current Quarters Estimate 0.198
FY Report Date 06 / 2026 Current Year's Estimate 0.786
Last Quarter’s Earnings 0.16 Median PE on CY Estimate N/A
Year Ago Earnings 0.90 Next Fiscal Year Estimate 0.845
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 18 18 18 18
Mean Estimate 0.20 0.21 0.79 0.85
High Estimates 0.21 0.22 0.81 0.94
Low Estimate 0.18 0.19 0.75 0.72
Coefficient of Variance 4.38 3.59 2.07 5.19

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 3 3 2
OVERWEIGHT 1 1 1
HOLD 13 13 16
UNDERWEIGHT 0 0 0
SELL 3 3 2
MEAN Hold Hold Hold

Insider Actions for Avantor Inc. - AVTR

Date Name Shares Transaction Value
Aug 13, 2025 Christophe Couturier EVP, AMEA 211,271 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00

Avantor Inc. in the News